CTLA4 and neoplasm: Results indicated that PLA2G7 depletion reduced MBT-2 tumor growth, and the combination of PLA2G7 depletion with CTLA4 blockade significantly improved the inhibitory effect on tumor burden (Fig. 8A, B).